TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Composite Efficacy Failure (Acute Rejection, Graft Loss, Death)
Endpoint domain: Mortality/survival
Primary endpoint: Change from Baseline Perceptions and Attitudes regarding children's weight status at 4 weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline Perceptions and Attitudes regarding children's food intake at 4 weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of pills to satisfy 80% of patients opioid needs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Patients Free From Progression
Endpoint domain: Mortality/survival
Primary endpoint: Ratios of carbon 13 to carbon 12 in breath
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in EGOMAC questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Global Ventilated Lung Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of the Yofimeter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Influenza Like Illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with self-reported HIV testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants with self-reported HIV self-testing (HIVST)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants with clinic-based HIV testing services (HTS)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Assessment of Posterior Nasal Cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of opioids taken during study period
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction of UP by more than 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to COVID-19 symptoms relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of severe stage of Covid19
Endpoint domain: Mortality/survival
Primary endpoint: Time to achieve peak sensory block without unimpaired motor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of graft material bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of the newly formed tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of EGFR mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: inflammatory signaling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: forearm blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants with treatment-related adverse events during pregnancy
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with treatment-related adverse events during post-partum period
Endpoint domain: Adverse events/effects
Primary endpoint: change in scar appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Plasma protein abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of ultrasound-guided injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Detected leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sleep efficiency (SE) index (%)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Successful block of the femoral and obturator nerves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduced muscle force compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cases of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of reported non serious and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: numeric pain rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: swelling at injury site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in sports activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Feasibility of polypectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recanalization Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: incidence of cardiovascular disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum lipid parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of Participants with an Adverse Event (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Global Clinical Impression Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Temperature accuracy compared to core body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement among temperatures taken in triplicate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test of cure visit at day 30
Endpoint domain: Adverse events/effects
Primary endpoint: Burden of influenza disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Influenza vaccine effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of infections in MS patients
Endpoint domain: Adverse events/effects
Primary endpoint: Change of average E/e'
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference of average E/e'
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Automate office blood pressure (AOBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes of depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Left Ventricular Wall Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incisional hernia formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Semiquantitative measurement of standardized uptake values (SUVs) of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from ordering to performing 12-lead ECGs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time from ordering to verifying 12-lead ECGs by ED physician
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average Time From Baseline to Recovery From Fever and Other Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in soft tissue thickness of keratinized mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ki-67 in Tumor Tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Regression of hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major Adverse Cardiac and Cerebrovascular Events (MACCEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of days achieving step goals
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Response rate determined by physical exam and appropriate imaging studies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxicity as assessed by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Premenstrual syndrome scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: WHOQOL-BREF-TR
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Analysis of blood and tissue leukocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline in UPSIT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantity of PrEP medications in the infant plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detectable and quantifiable concentrations of PrEP medications in the infant plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious adverse events in infants of breastfeeding HIV-uninfected women using PrEP
Endpoint domain: Adverse events/effects
Primary endpoint: Change in score of Stroke Knowledge Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in hospital readmission rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: UTI prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: swallowing efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine Toxicology Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving 50% improvement in distance walked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With NIHSS Score Improved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of high-grade immune-mediated adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in whole genome gene expression of duodenal mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Child restraint misuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prostate-specific antigen (PSA) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum urinary flow rate (Q max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: maximum cystometric capacity (MCC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: incidence of first uninhibited detrusor contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Penetration Aspiration Scale (PAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDR pathogens detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Parental Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in life satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: follicle growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: ovulation/anovulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Diagnosis of uterine niche
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first occurrence of an event
Endpoint domain: Mortality/survival
Primary endpoint: Change in parathyroid hormone serum concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Controlled LDL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of chromosomally abnormal and mosaic embryos
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Weight Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Eating Behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-Regulatory Control
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in horizontal width at crest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Pain Score at 4 Hours Postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of individual metabolites in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical validity of FACT-Hep
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Clinical validity of EORTC QLQ-HCC18
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Clinical validity of NFHSI-18
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sensitivity and Specificity of Intra-operative Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of safety events during cycling sessions
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of completing 80% of eligible cycling sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Suicidal behaviors and thinking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: All-cause Hospital Readmission Within 30 Days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in Total ADHD Symptoms Score at 24 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total ADHD Symptoms Score at 12 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Islet graft failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and phenotype of cells in adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean superior cup migration (subsidence)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foxp3 and Vimentin mRNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The change in blood sugar level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants Who Dropped Out of Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percent time in therapeutic range (TTR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck Pain And Disability Scale (NPDS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Neck and jaw range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of Anti-thrombotic Medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Early lineage-specific chimerism profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in fasting serum triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feasibility of delivering radiation treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of radiation treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy on human endogenous retrovirus-K (HERV-K(HML2))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxidative metabolism of APAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Follow-up Gingival Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean cardiac dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Trend of serum uric acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection of inflammatory atheromatous plaques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: platelet reactivity (PRU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Quality of Women's Health Care
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: words representing autonomy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Delta MPAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Delta RV GLS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Delta TAPSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Haemostatic Effect During Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number Of Hypoglycemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean CSFp
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Dose limiting toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Rupture risk equivalent diameter (RRED)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rupture risk-index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Preventing vomiting for 1st 24hrs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of SuperSTAT NIBP algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Vision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effect of bright light on fatigue as measured by PROMIS-Cancer Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Effect of bright light on sleep patterns as measured by PSG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect of bright light on quality of life as measured by EORCT QLQ C-30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Detection rate of Cu-64 PET imaging of PC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of joint space
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in cognitive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean Change in Total Number of Treated Mild Lesions Per Side
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of Dose-Limiting Toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting Adverse Events (AEs) and Serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in forced expired volume in the first second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change From Baseline in the Montreal Cognitive Assessment (MoCA) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Participants Based on CIBIC-Plus Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of somatic mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: EMG pelvic floor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Immediate reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Solicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Return of continence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sympathetic nerve activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevent <31 day readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Measure of Inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of semaphorins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of semaphorin gene polymorphism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief of Baby Blues Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Response Rates (Partial and Complete Responses)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: ordinal stroke severity at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: graft's artery resistance indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: hepatic/renal NIRS measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum metal ion level (Chromium and Cobalt)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of duration of the treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum S100B measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes